These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 2029801)

  • 1. Clinical pharmacology of omeprazole.
    Howden CW
    Clin Pharmacokinet; 1991 Jan; 20(1):38-49. PubMed ID: 2029801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.
    McTavish D; Buckley MM; Heel RC
    Drugs; 1991 Jul; 42(1):138-70. PubMed ID: 1718683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The second generation of gastric antisecretory agents: omeprazole].
    Souquet JC
    Rev Med Interne; 1988; 9(5):538-44. PubMed ID: 3067302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
    Hatlebakk JG; Berstad A
    Clin Pharmacokinet; 1996 Nov; 31(5):386-406. PubMed ID: 9118586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic evaluation of omeprazole.
    Adams MH; Ostrosky JD; Kirkwood CF
    Clin Pharm; 1988 Oct; 7(10):725-45. PubMed ID: 3069285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lansoprazole: a proton pump inhibitor.
    Garnett WR
    Ann Pharmacother; 1996 Dec; 30(12):1425-36. PubMed ID: 8968456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical utility and safety of omeprazole.
    Walan A
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():107-11. PubMed ID: 2657279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omeprazole: a comprehensive review.
    Massoomi F; Savage J; Destache CJ
    Pharmacotherapy; 1993; 13(1):46-59. PubMed ID: 8437967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole: a novel antisecretory agent for the treatment of acid-peptic disorders.
    Lampkin TA; Ouellet D; Hak LJ; Dukes GE
    DICP; 1990 Apr; 24(4):393-402. PubMed ID: 2183494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of gastric acid secretion. Histamine H2-receptor antagonists and H+K(+)-ATPase inhibitors.
    Shamburek RD; Schubert ML
    Gastroenterol Clin North Am; 1992 Sep; 21(3):527-50. PubMed ID: 1355465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Omeprazole in the therapy of acid-induced diseases].
    Simon B; Dammann HG; Müller P
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():146-51. PubMed ID: 2889299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lansoprazole: a comprehensive review.
    Zimmermann AE; Katona BG
    Pharmacotherapy; 1997; 17(2):308-26. PubMed ID: 9085323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole: a new approach to gastric acid suppression.
    Buhl K; Clearfield HR
    Am Fam Physician; 1990 Apr; 41(4):1225-7. PubMed ID: 2321497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of omeprazole on gastric acid secretion and plasma gastrin.
    Olbe L; Cederberg C; Lind T; Olausson M
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():19-25. PubMed ID: 2491358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of acid pump antagonists (reversible PPIs).
    Wurst W; Hartmann M
    Yale J Biol Med; 1996; 69(3):233-43. PubMed ID: 9165692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological basis of omeprazole therapy.
    Sachs G; Wallmark B
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():7-18. PubMed ID: 2562365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole: pharmacology, pharmacokinetics and interactions.
    Oosterhuis B; Jonkman JH
    Digestion; 1989; 44 Suppl 1():9-17. PubMed ID: 2691315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lansoprazol ++ : a new proton pump inhibitor].
    Baczek J; Laskowiec G
    Pol Merkur Lekarski; 1998 Jun; 4(24):339-41. PubMed ID: 9771021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.